Federal RuleAug 21
62
DOL Rewrites Disability Rules for 'Merit-Based Opportunity' Push
RuleLabor DepartmentFederal Contract Compliance Programs OfficeSignificant Wallet
119-hr-1794119th CongressWALLET
United States-Abraham Accords Cooperation and Security Act of 2025
Sponsored By: Representative Harshbarger, Diana [R-TN-1]
Introduced
Summary
Creates an FDA office to deepen regulatory cooperation with Abraham Accords countries. It would establish an Abraham Accords Office inside the Food and Drug Administration and, within two years after enactment, select a location in an Abraham Accords country and assign staff to carry out its work.
Show full summary
- Regulators in Abraham Accords countries would receive technical assistance to strengthen oversight and converge on manufacturing standards for medical products.
- Manufacturers and researchers in those countries would get clearer access to information on U.S. regulatory pathways and a channel to provide feedback on research, development, and manufacturing of FDA-regulated products.
- FDA and U.S. policymakers would place personnel overseas and receive a report to Congress within three years that evaluates progress, provides a numerical count of facilitated interactions, summarizes technical assistance, and offers recommendations. The office must act consistent with federal national security recommendations.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
New FDA office with Abraham Accords partners
The bill would create an Abraham Accords Office inside the FDA, led by a director. Within 2 years of enactment, HHS would pick a site in an Abraham Accords country and open the office after consulting U.S. and partner officials. The office would share FDA pathway information and help partners give feedback on research, development, and manufacturing. It would provide technical help to align rules, including good manufacturing practices. Actions could be delayed or skipped for national security reasons, and an Abraham Accords country would mean one the State Department says signed the declaration.
Sponsors & CoSponsors
Sponsor
Harshbarger, Diana [R-TN-1]
TN • R
Cosponsors
Rep. Vargas, Juan [D-CA-52]
CA • D
Sponsored 3/3/2025
Rep. Weber, Randy K. Sr. [R-TX-14]
TX • R
Sponsored 3/3/2025
Rep. Peters, Scott H. [D-CA-50]
CA • D
Sponsored 3/3/2025
Rep. Harris, Andy [R-MD-1]
MD • R
Sponsored 3/3/2025
Rep. Levin, Mike [D-CA-49]
CA • D
Sponsored 3/3/2025
Rep. Gottheimer, Josh [D-NJ-5]
NJ • D
Sponsored 1/30/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov